These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Exploring MicroRNA Biomarkers for Parkinson's Disease from mRNA Expression Profiles. Taguchi YH; Wang H Cells; 2018 Dec; 7(12):. PubMed ID: 30563060 [TBL] [Abstract][Full Text] [Related]
23. miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease. Wan Z; Rasheed M; Li Y; Li Q; Wang P; Li J; Chen Z; Du J; Deng Y Mol Neurobiol; 2023 Oct; 60(10):5642-5654. PubMed ID: 37329382 [TBL] [Abstract][Full Text] [Related]
24. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Waragai M; Wei J; Fujita M; Nakai M; Ho GJ; Masliah E; Akatsu H; Yamada T; Hashimoto M Biochem Biophys Res Commun; 2006 Jul; 345(3):967-72. PubMed ID: 16707095 [TBL] [Abstract][Full Text] [Related]
25. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase. Tan Y; Ge G; Pan T; Wen D; Gan J Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA Expression Profile Changes in the Leukocytes of Parkinson's Disease Patients. Ardashirova NS; Abramycheva NY; Fedotova EY; Illarioshkin SN Acta Naturae; 2022; 14(3):79-84. PubMed ID: 36348717 [TBL] [Abstract][Full Text] [Related]
27. Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson's Disease. Chen Y; Zheng J; Su L; Chen F; Zhu R; Chen X; Ye Q Front Aging Neurosci; 2020; 12():210. PubMed ID: 32733234 [TBL] [Abstract][Full Text] [Related]
28. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Chen Y; Zeng L; Wang Y; Tolleson WH; Knox B; Chen S; Ren Z; Guo L; Mei N; Qian F; Huang K; Liu D; Tong W; Yu D; Ning B Biochem Pharmacol; 2017 Dec; 145():178-191. PubMed ID: 28822783 [TBL] [Abstract][Full Text] [Related]
29. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease. Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642 [TBL] [Abstract][Full Text] [Related]
30. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses. Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512 [TBL] [Abstract][Full Text] [Related]
31. Serum miR-221 serves as a biomarker for Parkinson's disease. Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571 [TBL] [Abstract][Full Text] [Related]
32. The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson's disease. Liang J; Wan Z; Qian C; Rasheed M; Cao C; Sun J; Wang X; Chen Z; Deng Y Cell Mol Biol Lett; 2024 Jan; 29(1):7. PubMed ID: 38172670 [TBL] [Abstract][Full Text] [Related]
33. miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease. Dos Santos MCT; Barreto-Sanz MA; Correia BRS; Bell R; Widnall C; Perez LT; Berteau C; Schulte C; Scheller D; Berg D; Maetzler W; Galante PAF; Nogueira da Costa A Oncotarget; 2018 Apr; 9(25):17455-17465. PubMed ID: 29707120 [TBL] [Abstract][Full Text] [Related]
34. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
35. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers. Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108 [TBL] [Abstract][Full Text] [Related]
36. MiR-323b-5p acts as a novel diagnostic biomarker for critical limb ischemia in type 2 diabetic patients. Cheng B; Li JY; Li XC; Wang XF; Wang ZJ; Liu J; Deng AP Sci Rep; 2018 Oct; 8(1):15080. PubMed ID: 30305681 [TBL] [Abstract][Full Text] [Related]
37. Senescence-associated microRNAs target cell cycle regulatory genes in normal human lung fibroblasts. Markopoulos GS; Roupakia E; Tokamani M; Vartholomatos G; Tzavaras T; Hatziapostolou M; Fackelmayer FO; Sandaltzopoulos R; Polytarchou C; Kolettas E Exp Gerontol; 2017 Oct; 96():110-122. PubMed ID: 28658612 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma. Zeybek A; Öz N; Kalemci S; Edgünlü T; Kızıltuğ MT; Tosun K; Tunç M; Tekin L; Erdal ME Curr Mol Med; 2019; 19(3):216-227. PubMed ID: 30868951 [TBL] [Abstract][Full Text] [Related]
39. Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases. Mayo S; Benito-León J; Peña-Bautista C; Baquero M; Cháfer-Pericás C Curr Neuropharmacol; 2021; 19(8):1273-1303. PubMed ID: 33357195 [TBL] [Abstract][Full Text] [Related]
40. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP. Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]